Intrathecal immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial
<p>Despite long-standing availability of an effective vaccine, tetanus remains a significant problem in many countries. Outcome depends on access to mechanical ventilation and intensive care facilities and in settings where these are limited, mortality remains high. Administration of tetanus a...
Main Authors: | Loan, H, Yen, L, Kestelyn, E, Hao, N, Thanh, T, Dung, N, Turner, H, Geskus, R, Wolbers, M, Tan, L, Van Doorn, H, Day, N, Wyncoll, D, Hien, T, Thwaites, G, Vinh Chau, N, Thwaites, C |
---|---|
פורמט: | Journal article |
יצא לאור: |
F1000Research
2018
|
פריטים דומים
-
Intrathecal Immunoglobulin for treatment of adult patients with tetanus: A randomized controlled 2x2 factorial trial
מאת: Loan, H, et al.
יצא לאור: (2018) -
A pilot study to assess safety and feasibility of Intrathecal Immunoglobulin for the treatment of adults with Tetanus
מאת: Loan, H, et al.
יצא לאור: (2018) -
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial
מאת: Van Hao, N, et al.
יצא לאור: (2022) -
Predicting the clinical outcome of tetanus: the tetanus severity score.
מאת: Thwaites, C, et al.
יצא לאור: (2006) -
Urinary catecholamine excretion, cardiovascular variability, and outcomes in tetanus
מאת: Du, DH, et al.
יצא לאור: (2023)